194 related articles for article (PubMed ID: 32916636)
1. Establishment of a human induced pluripotent stem cell line, JUCTCi012-A, from multiple symmetric lipomatosis (MSL) patient carrying a homozygous Arg707Trp (c.2119C > T) mutation in the MFN2 gene.
Ababneh NA; Ali D; Barham R; Al-Kurdi B; Sharar N; Al Hadidi S; Qanno' O; Ryalat AT; Salah B; Awidi A
Stem Cell Res; 2020 Oct; 48():101967. PubMed ID: 32916636
[TBL] [Abstract][Full Text] [Related]
2. Generation of a human induced pluripotent stem cell (iPSC) line (JUCTCi019-A) from a patient with Charcot-Marie-Tooth disease type 2A2 (CMT2A2) due to a heterozygous missense substitution c.2119C > T (p.Arg707Trp) in MFN2 gene.
Ababneh NA; Barham R; Al-Kurdi B; Ali D; Hadidi SA; A Ismail M; Muamar ASH; Abdulelah AA; Madadha A; Sallam M; Hassona Y; Masri A; Awidi A
Stem Cell Res; 2022 Jul; 62():102786. PubMed ID: 35468369
[TBL] [Abstract][Full Text] [Related]
3. Homozygous mutations in MFN2 cause multiple symmetric lipomatosis associated with neuropathy.
Sawyer SL; Cheuk-Him Ng A; Innes AM; Wagner JD; Dyment DA; Tetreault M; ; Majewski J; Boycott KM; Screaton RA; Nicholson G
Hum Mol Genet; 2015 Sep; 24(18):5109-14. PubMed ID: 26085578
[TBL] [Abstract][Full Text] [Related]
4. Generation of induced pluripotent stem cell line, ZJUCHi002-A, from Charcot-Marie-Tooth disease type 2A (CMT2A) patient with a mutation of c.752C>T in MFN2.
Xu J; Fu Y; Xia W; He J; Zou Y; Ruan W; Lou Q; Li Y; Pan J; Li H; Chen W
Stem Cell Res; 2019 Apr; 36():101411. PubMed ID: 30807887
[TBL] [Abstract][Full Text] [Related]
5. MFN2-associated lipomatosis: Clinical spectrum and impact on adipose tissue.
Capel E; Vatier C; Cervera P; Stojkovic T; Disse E; Cottereau AS; Auclair M; Verpont MC; Mosbah H; Gourdy P; Barraud S; Miquel A; Züchner S; Bonnefond A; Froguel P; Christin-Maitre S; Delemer B; Fève B; Laville M; Robert J; Tenenbaum F; Lascols O; Vigouroux C; Jéru I
J Clin Lipidol; 2018; 12(6):1420-1435. PubMed ID: 30158064
[TBL] [Abstract][Full Text] [Related]
6. Generation of two induced pluripotent stem cells lines from a Mucopolysaccharydosis IIIB (MPSIIIB) patient.
Vallejo-Diez S; Fleischer A; Martín-Fernández JM; Sánchez-Gilabert A; Bachiller D
Stem Cell Res; 2018 Dec; 33():180-184. PubMed ID: 30408744
[TBL] [Abstract][Full Text] [Related]
7. Generation of an induced pluripotent stem cell (iPSC) line (JUCTCi017-A) from a patient with limb-girdle muscular dystrophy (LGMD) due to a homozygous p.Lue287Ser fs14* mutation in the SGCB gene.
Ababneh NA; Barham R; Al-Kurdi B; Ali D; Sharar N; Al Hadidi S; Alatoom RM; Zalloum S; Gharandouq MH; Makahleh L; Alnsour LN; Alshahwan H; El-Khateeb M; Awidi A
Stem Cell Res; 2021 Jul; 54():102358. PubMed ID: 34087734
[TBL] [Abstract][Full Text] [Related]
8. Generation of an induced pluripotent stem cell (iPSC) line (THSJTUi001-A) from a Wilson's disease patient harboring a homozygous Arg778Leu mutation in ATP7B gene.
Wang SH; Wang XP
Stem Cell Res; 2020 Dec; 49():102050. PubMed ID: 33096383
[TBL] [Abstract][Full Text] [Related]
9. Calcyphosine-like (CAPSL) is regulated in Multiple Symmetric Lipomatosis and is involved in Adipogenesis.
Lindner A; Marbach F; Tschernitz S; Ortner C; Berneburg M; Felthaus O; Prantl L; Kye MJ; Rappl G; Altmüller J; Thiele H; Schreml S; Schreml J
Sci Rep; 2019 Jun; 9(1):8444. PubMed ID: 31186450
[TBL] [Abstract][Full Text] [Related]
10. Generation of induced pluripotent stem cell line (ZZUi007-A) from a 52-year-old patient with a novel CHCHD2 gene mutation in Parkinson's disease.
Wang Y; Wang Z; Sun H; Mao C; Yang J; Liu Y; Liu H; Zhang S; Zhang J; Xu Y; Shi C
Stem Cell Res; 2018 Oct; 32():87-90. PubMed ID: 30237140
[TBL] [Abstract][Full Text] [Related]
11. Generation of induced pluripotent stem cell line (RCMGi001-A) from human skin fibroblasts of a cystic fibrosis patient with p.F508del mutation.
Kondrateva E; Adilgereeva E; Amelina E; Tabakov V; Demchenko A; Ustinov K; Yasinovsky M; Voronina E; Lavrov A; Smirnikhina S
Stem Cell Res; 2020 Oct; 48():101933. PubMed ID: 32777768
[TBL] [Abstract][Full Text] [Related]
12. Generation of an induced pluripotent stem cell line, FJMUUHi001-A, from a hereditary Parkinson's disease patient with homozygous mutation of c.189dupA in PARK7.
Chen ZT; Zhao ZH; Chen LN; Fan F; Cai GE; Weng HD; Wang YQ; Liao LM; Chen XC; Huang E; Ye QY
Stem Cell Res; 2021 Mar; 51():102175. PubMed ID: 33485186
[TBL] [Abstract][Full Text] [Related]
13. Generation of induced pluripotent stem cells (iPSCs) IRMBi002-A from an Alzheimer's disease patient carrying a D694N mutation in the APP gene.
Auboyer L; Monzo C; Wallon D; Rovelet-Lecrux A; Gabelle A; Gazagne I; Cacheux V; Lehmann S; Crozet C
Stem Cell Res; 2019 May; 37():101438. PubMed ID: 31004935
[TBL] [Abstract][Full Text] [Related]
14. Establishment of induced pluripotent stem cell line (ZZUi009-A) from an Alzheimer's disease patient carrying a PSEN1 gene mutation.
Wang Y; Jing N; Su L; Shi C; Zhang P; Wang Z; Sun H; Yang J; Liu Y; Wen X; Zhang J; Zhang S; Xu Y
Stem Cell Res; 2018 Mar; 27():30-33. PubMed ID: 29304399
[TBL] [Abstract][Full Text] [Related]
15. Generation of a human induced pluripotent stem cell (iPSC) line (JUCTCi011-A) from skin fibroblasts of a healthy Jordanian male subject.
Ababneh NA; Al-Kurdi B; Ali D; Barham R; Sharar N; Mrahleh MM; Salah B; Awidi A
Stem Cell Res; 2020 Oct; 48():101923. PubMed ID: 32771906
[TBL] [Abstract][Full Text] [Related]
16. Establishment of an induced pluripotent stem cell line from a Antley-Bixler Syndrome (ABS) patient with the homozygote mutation p.R457H (c.1370G>A) in POR gene.
Guo X; Wang D; Shan X; Yang L; Ding Y; Chen H; Rong X; Chu M; Lin J; Chen C
Stem Cell Res; 2021 Apr; 52():102261. PubMed ID: 33631521
[TBL] [Abstract][Full Text] [Related]
17. Generation of induced pluripotent stem cells (iPSCs) from a retinoblastoma patient carrying a c.2663G>A mutation in RB1 gene.
Zeng S; Liu L; Ouyang Q; Zhao Y; Lin G; Hu L; Li W
Stem Cell Res; 2016 Sep; 17(2):208-211. PubMed ID: 27879208
[TBL] [Abstract][Full Text] [Related]
18. Fibroblast-derived integration-free iPSC line ISRM-NBS1 from an 18-year-old Nijmegen Breakage Syndrome patient carrying the homozygous NBN c.657_661del5 mutation.
Martins S; Bohndorf M; Graffmann N; Wruck W; Chrzanowska KH; Adjaye J
Stem Cell Res; 2019 Jan; 34():101372. PubMed ID: 30616142
[TBL] [Abstract][Full Text] [Related]
19. Generation of an induced pluripotent stem cell line from a Bartter syndrome patient with the homozygote mutation p.A244D (c.731C>A) in SLC12A1 gene.
Ji W; Wang D; Chen C; Chen H; Ding Y; Li C; Rong X; Shan X; Chu M; Shen X; Guo X
Stem Cell Res; 2021 Apr; 52():102228. PubMed ID: 33607471
[TBL] [Abstract][Full Text] [Related]
20. Generation and characterization of a human induced pluripotent stem cell (iPSC) line (HEBHMUi001-A) from a sporadic Parkinson's disease patient.
Ma J; Guo R; Song Y; Zhang J; Feng B; Amponsah AE; Kong D; He J; Zhang W; Liu A; Wei L; Shen S; O'Brien T; Cui H
Stem Cell Res; 2019 Apr; 36():101417. PubMed ID: 30875588
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
